Literature DB >> 23919213

Steroid ulcers: Any news?

Mario Guslandi1.   

Abstract

Steroid ulcers, although a common feature in experimental studies, seldom develop in clinical practice, as observed by the meta-analyses carried out in the 90s. Corticosteroids alone become ulcerogenic only if treatment lasts longer than one month and the total administered dose exceeds 1000 mg. On the other hand concomitant intake of non-steroidal anti-inflammatory drugs results in a synergistic, highly damaging effect on the gastroduodenal mucosa. Thus, despite the survival of the steroid ulcer myth in the medical culture, pharmacological protection against steroid-induced peptic ulcers is a rare necessity while the best prophylactic strategy still remains to be determined.

Entities:  

Keywords:  Cortcosteroids; Peptic ulcer; Proton pump inhibitors

Year:  2013        PMID: 23919213      PMCID: PMC3729864          DOI: 10.4292/wjgpt.v4.i3.39

Source DB:  PubMed          Journal:  World J Gastrointest Pharmacol Ther        ISSN: 2150-5349


  13 in total

Review 1.  Nonassociation of adrenocorticosteroid therapy and peptic ulcer.

Authors:  H O Conn; B L Blitzer
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

2.  Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs.

Authors:  J M Piper; W A Ray; J R Daugherty; M R Griffin
Journal:  Ann Intern Med       Date:  1991-05-01       Impact factor: 25.391

Review 3.  Epidemiology of NSAID-related gastroduodenal mucosal injury.

Authors:  C Aalykke; K Lauritsen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2001-10       Impact factor: 3.043

4.  "A surviving myth"--corticosteroids are still considered ulcerogenic by a majority of physicians.

Authors:  Jan Martínek; Kristyna Hlavova; Filip Zavada; Bohumil Seifert; Stanislav Rejchrt; Ondrej Urban; Miroslav Zavoral
Journal:  Scand J Gastroenterol       Date:  2010-10       Impact factor: 2.423

5.  Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial.

Authors:  F E Silverstein; D Y Graham; J R Senior; H W Davies; B J Struthers; R M Bittman; G S Geis
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

6.  Non-ulcerogenic dose of dexamethasone delays gastric ulcer healing in rats.

Authors:  Jiing C Luo; Vivian Y Shin; Edgar S L Liu; Wallace H L So; Yi N Ye; Full Y Chang; Chi H Cho
Journal:  J Pharmacol Exp Ther       Date:  2003-09-09       Impact factor: 4.030

7.  Corticosteroids reduce regenerative repair of epithelium in experimental gastric ulcers.

Authors:  M Carpani de Kaski; R Rentsch; S Levi; H J Hodgson
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

8.  Dexamethasone delays ulcer healing by inhibition of angiogenesis in rat stomachs.

Authors:  Jiing C Luo; Vivian Y Shin; Edgar S L Liu; Yi N Ye; William K K Wu; Wallace H L So; Full Y Chang; Chi H Cho
Journal:  Eur J Pharmacol       Date:  2004-02-06       Impact factor: 4.432

9.  Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy.

Authors:  H O Conn; T Poynard
Journal:  J Intern Med       Date:  1994-12       Impact factor: 8.989

10.  Association of adrenocorticosteroid therapy and peptic-ulcer disease.

Authors:  J Messer; D Reitman; H S Sacks; H Smith; T C Chalmers
Journal:  N Engl J Med       Date:  1983-07-07       Impact factor: 91.245

View more
  7 in total

1.  Peptic ulcer disease in endogenous hypercortisolism: myth or reality?

Authors:  Esra Hatipoglu; Asli Sezgin Caglar; Erkan Caglar; Serdal Ugurlu; Murat Tuncer; Pinar Kadioglu
Journal:  Endocrine       Date:  2015-04-21       Impact factor: 3.633

2.  Glucocorticoids and the Risk of Peptic Ulcer Bleeding: Case-Control Analysis Based on Swiss Claims Data.

Authors:  Daphne Reinau; Matthias Schwenkglenks; Mathias Früh; Andri Signorell; Eva Blozik; Christoph R Meier
Journal:  Drug Saf       Date:  2018-07       Impact factor: 5.606

3.  Comparison Between Lidocaine Inhalation and Intravenous Dexamethasone in Reducing Postoperative Sore Throat Frequency After Laryngeal Mask Insertion.

Authors:  Susilo Chandra; Pryambodho Pryambodho; Annemarie Chrysantia Melati; Rizki Iwan Kusuma
Journal:  Anesth Pain Med       Date:  2018-08-25

Review 4.  The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I - Diagnosis and treatment of the first episode and the first relapse.

Authors:  Andrea Pasini; Elisa Benetti; Giovanni Conti; Luciana Ghio; Marta Lepore; Laura Massella; Daniela Molino; Licia Peruzzi; Francesco Emma; Carmelo Fede; Antonella Trivelli; Silvio Maringhini; Marco Materassi; Giovanni Messina; Giovanni Montini; Luisa Murer; Carmine Pecoraro; Marco Pennesi
Journal:  Ital J Pediatr       Date:  2017-04-21       Impact factor: 2.638

5.  Upper gastrointestinal ischemia as a rare complication of paroxysmal nocturnal hemoglobinuria.

Authors:  Masayuki Ueno; Yuichi Shimodate; Kazuya Okada; Ryosuke Takaya; Hiroshi Yamamoto; Motowo Mizuno
Journal:  Clin Case Rep       Date:  2020-11-22

Review 6.  Systemic corticosteroids for management of COVID-19: Saving lives or causing harm?

Authors:  Alireza FakhriRavari; Stephanie Jin; Farrnam H Kachouei; Diana Le; Mireya Lopez
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

Review 7.  Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.

Authors:  Carmelo Scarpignato; Luigi Gatta; Angelo Zullo; Corrado Blandizzi
Journal:  BMC Med       Date:  2016-11-09       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.